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Abstract
Background: Excessive production of inflammatory mediators such as nitric oxide (NO) and proinflammatory
cytokines like tumour necrosis factor-alpha (TNF-α) from activated microglia contributes to uncontrolled inflammation
in neurodegenerative diseases. This study investigated the protective role of five endophytic extracts (HAB16R12,
HAB16R13, HAB16R14, HAB16R18 and HAB8R24) against LPS-induced inflammatory events in vitro. These endophytic
extracts were previously found to exhibit potent neuroprotective effect against LPS-challenged microglial cells.
Methods: The effects of these fungal endophytic extracts against nitric oxide (NO), CD40 phenotype and, pro- and
anti-inflammatory cytokine production in lipopolysaccharide (LPS)-stimulated BV2 microglia cells were examined using
commercially available assay kits, immunophenotyping and flow cytometry, respectively.
Results: Microglia pre-treated with the five endophytic extracts (0.1 mg/mL) reduced NO production without
compromising cell viability. Whilst CD40 expression in LPS-stimulated microglia was not significantly different
with or without the influence of endophytic extracts, expression of the proinflammatory cytokines, IL-6 and
TNF-α in LPS-stimulated microglia was significantly (P < 0.05) inhibited by these endophytic extracts.
Conclusions: The outcomes suggest that the neuroprotective effect of the fungal endophytic extracts is likely
mediated through supression of neuroinflammation. To our knowledge, this is the first report of the effect of
a fungal endophytic extract in controlling inflammation in BV2 microglia cells.
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Background
Inflammation in the brain was previously observed only as
a reactive response to neuronal damage [1]. There is in-
creasing evidence, however, indicating that inflammation
also causes neuronal death and damage [2] which in turn
leads to neurodegenerative diseases such as Alzheimer’s
disease, Parkinson’s disease and multiple sclerosis. Amongst
the various cell types associated with inflammation-
mediated neurodegeneration, microglia have been implicated
as vital components of the immunological insult to
neurons [3].
Microglia account for approximately 12 % of cell popu-
lation [4] in the central nervous system (CNS). They are
brain-specific macrophages that provide trophic support
and maintains homeostasis in healthy tissue [5]. During
brain infection or injury, microglia become activated and
up-regulate a variety of surface receptors which include
the major histocompatibility complex and complement
receptors [1]. They also release various pro-survival
neurotrophic factors like brain-derived neurotrophic fac-
tor (BDNF), neurotrophin-3 (NT-3) and nerve growth fac-
tor (NGF) [6], and proinflammatory molecules such as
tumour necrosis factor alpha (TNF-α), interleukin 1 beta
(IL-1β) and free radicals nitric oxide (NO) and superoxide
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anion. All these may lead to a beneficial inflammatory re-
sponse and recovery. Nevertheless, over-activation of micro-
glia can cause neuronal toxicity and death, exacerbating
neurodegenerative diseases [7]. It is now generally ac-
cepted that microglial activation is involved in the ini-
tiation and progression of multiple neurodegenerative
diseases [8]. Therefore, early detection of microglial acti-
vation and anti-inflammatory therapy may delay or halt
disease progression before irreversible damage and clinical
symptoms occur.
Medicinal plants, plant extracts and isolated secondary
metabolites have traditionally been used to treat a variety
of diseases including those associated with acute and
chronic inflammation [9]. Endophytic fungi which form
symbiotic associations with plants and often produce pro-
tective compounds for their hosts, however, remain one of
the most unexplored group of microorganisms for their
protective effects against inflammation [10]. In a recent
report,, five extracts (HAB16R12, HAB16R13, HAB16R14,
HAB16R18 and HAB8R24) with potent BACE 1 inhibitory
activity were identified from amongst 212 endophytic ex-
tracts [11]. These extracts showed potential to be devel-
oped into therapeutics that can be used for treatment
against neurodegenerative diseases. Given the relationship
between BACE1 expression and inflammation [12], the
present study investigated for the possible role of these ex-
tracts with BACE1 inhibitory effect in modulating in vitro




Fungal endophytes were obtained from the culture col-
lection of the Collaborative Drug Discovery Research
(CDDR) Group, Faculty of Pharmacy, Universiti Teknologi
MARA (UiTM), Malaysia. They were previously isolated
from medicinal plants at Kuala Pilah rainforest in Negeri
Sembilan, Malaysia [13]. Axenic cultures were maintained on
potato dextrose agar (PDA, Oxoid, Basingstoke, Hampshire,
England) plates and incubated at 28 °C for 14 days. Five
endophytic fungi (HAB16R12, HAB16R13, HAB16R14,
HAB16R18 and HAB8R24) cultures were extracted and
assessed for their bioactivity. These fungi were all isolated
from the roots of Cinnamomum porrectum [11, 13]. The
ITS of HAB10R12, HAB16R13, HAB16R14, HAB16R18 and
HAB8R24 were found to be 586–593 bp in length. A BLAST
search of the ITS of all five isolates revealed that they
were 98–99 % identical to Cytospora rhizophorae [11]. Their
GenBank accession numbers were JN083836, HQ336045,
JN083837, JN083838 and JN083839, respectively.
Semipolar extraction of fungal cultures
Semipolar extraction was performed as described by NA
Hazalin, K Ramasamy, SM Lim, IA Wahab, AL Cole and
AB Abdul Majeed [14]. Briefly, after 14 days of incubation,
10 plates of each fungus were transferred into a conical
flask (500 mL) and homogenised (Kika Labortechnik T25,
Staufen, Germany). Ethyl acetate (200 mL) was added and
left to stir overnight at room temperature. The mixture
was filtered through Whatman No.1 filter paper, after
which sodium sulphate (Merck, Darmstadt, Germany) was
added to remove the aqueous layer within the mixture.
The mixture was then transferred to a round bottom flask
(500 mL) and evaporated to dryness. The resultant extract
was dissolved in 1 mL dimethyl-sulfoxide (DMSO) (Sigma,
St Louis, Missouri, USA) and stored at -20 °C until further
use.
BV2 microglia cell line
The BV2 microglia cell line was provided by Dr. Sharmili
Vidyadaran (Universiti Putra Malaysia, UPM) and main-
tained in Dulbecco’s Modified Eagle Medium (DMEM)
(Gibco, Grand Island, New York, USA) with 5 % heat-
inactivated foetal bovine serum, 100 U/mL penicillin, 100
μg/mL streptomycin, 1 mL/L gentamycin (all Invitrogen,
Grand Island, New York, USA), 6.25 μg/mL insulin
(Sigma, St Louis, Missouri, USA), 1 × non-essential amino
acids (Sigma, St Louis, Missouri, USA) and 1.5 g/L sodium
bicarbonate (NaHCO3) (Sigma, St Louis, Missouri, USA)
at 37 °C with 5 % CO2 unless otherwise stated [15].
Griess assay for Nitric Oxide (NO) production
The Griess assay measures the level of accumulated ni-
trite (NO2
−), a metabolite of nitric oxide (NO) in culture
supernatant using the Griess reagent [2.5 % phosphoric
acid (Merck, Darmstadt, Germany), 1 % sulphanilamide
(Sigma, St Louis, Missouri, USA) and 0.1 % napthy ethyl-
ene diamine dihydrochloride (Sigma, St Louis, Missouri,
USA)]. Cells were plated in 96-well microtiter plates at a
density of 1 × 105 cells per well and incubated for 24 h.
Cells were then treated with medium supplemented with
endophytic extracts (0.1–1000 μg/mL) and after 24 h, the
media was changed to 250 μL DMEM (without phenol
red) per well and the standard iNOS inhibitor, N-nitro-
L-arginine methyl ester (L-NAME) (250 μM) (Sigma, St
Louis, Missouri, USA) added to designated wells. The cells
were then stimulated with 1 μg/mL lipopolysaccharide
(LPS). Supernatants were collected at 18, 24 and 48 h for
nitrite (NO2
−) production assay. An equal volume of
Griess reagent was mixed with cell culture supernatants
and color development assessed at absorbance 530 nm
with a microplate reader (MRX® II, Dynex Technologies,
Chantilly, Virginia, USA). The amount of NO2
− in the
samples was calculated from a standard curve (0–100 μM)
of freshly prepared sodium nitrite. Cell viability was deter-
mined using the MTT reduction assay [16] after 24 h and
48 h.
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Cell viability assay
Cells were plated in 96-well microtiter plates at a density
of 1 × 105 cells per well and incubated for 24 h. Cells were
then treated with medium supplemented with endophytic
extracts (0.1–1000 μg/mL) for 24 h. The media was chan-
ged to 250 μL DMEM per well and the cells were stimu-
lated with 1 μg/mL lipopolysaccharide (LPS) for 24 h and
48 h, respectively, after which MTT assay was performed.
Under dark conditions, 10 μL of 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) (Sigma, Schnelldorf,
Germany) solution (5 mg/mL in PBS) was added to BV2
cells in each 96 well plate containing 100 μL media and
incubated for 3 h. MTT solution was removed and 200 μL
dimethyl sulfoxide (DMSO) was added to dissolve the for-
mazan dye. The plate was shaken for 3 min and absorb-
ance determined at 570 nm using a microplate reader
(MRX® II, Dynex Technologies, Chantilly, Virginia, USA).
Immunophenotyping
BV2 microglia cells were seeded in a 12-well plate at a
seeding density of 2 × 105 cells per well, incubated for 24 h
and then treated with endophytic extracts at 0.1 mg/mL
(extracts exhibited not more than 30 % cell kill at this con-
centration) and incubated for 24 h. Cells were then stimu-
lated with LPS (1 μg/mL) and incubated for 18, 24 and 48
h under the same conditions. Cells were harvested by
trypsinisation with 0.25 % trypsin (200 μL per well) for 5
min. Media (600 μL) was added to stop the trypsinisation
and then transferred into the fluorescence activated cell
sorting (FACS) tube, spun down at 2000 rpm for 5 min
and cell pellet collected. The cell pellet was washed in
1 mL PBS/0.2 % bovine serum albumin (BSA) and spun
down at 2000 rpm for 5 min. Under dark conditions, anti-
CD40-FITC (BD Biosciences) was added to the pellet and
subsequently incubated at 4 °C for 30 min. Isotype-
matched antibodies to FITC was used as control to deter-
mine non-specific staining. BSA (0.2 %in PBS; 1 mL) was
added and mixture spun down at 2000 rpm for 5 min.
The resultant cell pellet was resuspended in 500 μL 0.2 %
BSA in PBS and analysed using a FACSCalibur cytometer
(BD Biosciences, San Jose, CA). A total of 10,000 cells
(events acquired) were selected for analysis.
Cytokine assay
BV2 microglia cells were seeded onto a 6-well plate at a
density of 2 × 105 cells per well and incubated for 24 h.
The cells were then treated with 0.1 mg/mL endophytic
extracts and incubated for 24 h. Treated cells were stim-
ulated with LPS (1 μg/mL) and incubated for 24 and
48 h. The supernatant was collected and assayed for inter-
leukin (IL)-6, IL-10, IL-12p70, tumor necrosis factor alpha
(TNF-α), monocyte chemoattractant protein-1 (MCP-1)
and interferon-gamma (IFN-γ). The Becton Dickson
Cytometric Bead Array (CBA) Mouse Inflammation Kit
(BD Biosciences, San Diego, California, USA) which cap-
tures a soluble analyte or set of analytes with beads of
known size and fluorescence was employed and analysed
using BD FACSCalibur flow cytometer (BD Biosciences,
San Diego, California, USA) and BD CellQuest Pro soft-
ware (BD Biosciences, San Diego, California, USA). Briefly,
50 μL of each test sample supernatant was transferred into
assay tubes. The mixed capture beads (CB, 50 μL) was
added to the assay tubes containing test samples and to
the control tubes [50 μL of the mouse inflammation stan-
dards (MIS) dilutions]. Then, 50 μL of the mouse inflam-
mation PE detection reagents were added to the entire test
assay tubes and incubated for 2 h at room temperature in
darkness. Wash buffer (1 mL) was added to each assay
tube and centrifuged at 200 × g for 5 min. The bead pellet
was resuspended in 300 μL wash buffer and analysed using
FACSCalibur cytometer (BD Biosciences, San Jose, CA).
The BD FACSCalibur flow cytometer is a four-color, dual
laser and bench top flow cytometry system that provides
both cell analysis and sorting. For intra-assay precision, ten
replicates of each of the three different levels of IL-6, IL10,
MCP-1, IFN-γ, TNF-α and IL-12p70 were tested and for
inter-assay precision, three different levels of IL-6, IL10,
MCP-1, IFN-γ, TNF-α and IL-12p70 (80, 625, 2500 pg/mL)
were tested in four experiments. The detection limit of
IL-6, IL10, MCP-1, IFN-γ, TNF-α and IL-12p70 is 5, 17.5,
52.7, 2.5, 7.3 and 10.7 pg/mL, respectively.
Statistical analysis
Differences in the anti-inflammatory effects of the ex-
tracts after treatment were evaluated using the One-Way
ANOVA procedure of the SPSS version 17.0. When there
was a difference, the LSD’s post hoc test was used to iden-
tify pairs that differed significantly. Differences were con-
sidered as significant at P < 0.05.
Results
Pre-treatment of BV2 microglial cells with endophytic
extracts offers protection against oxidative stress through
attenuation of LPS-induced NO production
NO (~20 μM) was present in unstimulated BV2 microglia
cells (resting cells) at all time points (Fig. 1). The basal
level of NO was markedly increased to 54 μM (2.7 fold),
76 μM (3.8 fold) and 145 μM (7.3 fold) after exposure to
LPS for 18 h, 24 h and 48 h, respectively (Fig. 1). Pre-
treatment of BV2 with all five extracts at 0.1 mg/mL and
1.0 mg/mL significantly reduced subsequent LPS-induced
NO production (Fig. 1; P < 0.05). For pre-treatment at
0.1 mg/mL, NO was significantly reduced by approxi-
mately 57.5–66.1 %, 64.2–74.7 % and 61.6–74.4 % fol-
lowing exposure to LPS for 18, 24 and 48 h, respectively
(P < 0.05). Pre-treatment with extracts at lower concentra-
tions (0.01–0.0001 mg/mL), however, reduced NO pro-
duction by only 6.6–21.8 %, 8.0–19.7 % and 4.8–18.8 %
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following exposure to LPS for 18 h, 24 h and 48 h, re-
spectively. For pre-treatment at 1.0 mg/mL NO produc-
tion was significantly (P < 0.05) reduced by approximately
61.5–65.9 %, 68.9–76.0 % and 85.0–86.4 % following
exposure to LPS for 18 h, 24 h and 48 h, respectively.
The iNOS inhibitor, L-NAME (250 μM) that was added
to BV2 simultaneously with LPS, significantly (P < 0.05)
reduced NO production by 46.0 %, 50.7 % and 53.4 %
at 18 h, 24 h and 48 h, respectively. The present study
found the NO lowering effect of pre-treatment with endo-
phytic extracts (0.1–1 mg/mL) to be either comparable to
(at 0.1 mg/mL) or otherwise better (at 1.0 mg/mL) than
that of standard nitric oxide synthase (NOS) inhibitor,
L-NAME. It is noteworthy that the protective effects of
pre-treatment with endophytic extracts as observed had
no effect on basal NO release by microglia (Additional
file 1: Figure S1).
Pre-treatment with endophytic extracts were not
cytotoxic against BV2 microglia cells at concentrations <
1.0 mg/ml
Except for 1.0 mg/mL (<40 % cell viability; P < 0.05),
pre-treatment with all five extracts did not significantly
affect the cell viability of BV2 microglia cells between con-
centrations of 0.0001–0.1 mg/mL, with or without LPS
(Fig. 2). As such, the highest subtoxic concentration of the
extract (0.1 mg/mL), which exhibited good NO lowering
effect without affecting cell viability, were chosen for sub-
sequent anti-inflammatory study.
Endophytic extracts altered CD40 expression on
unstimulated BV2 microglia cells but not their stimulated
counterparts
The subtoxic extracts (0.1 mg/mL) were examined for
their suppressive effects against CD40 expression on
Fig. 1 Effects of pre-treatment with extracts HAB16R12 (a), HAB16R13 (b), HAB16R14 (c), HAB16R18 (d) and HAB8R24 (e) on NO production in
LPS-stimulated BV2 microglia cells. Data are expressed as means ± SEM of three independent experiments. *P < 0.05, significantly different when
compared to LPS-treated control (BV2)
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LPS-stimulated BV2 microglia cells. BV2 cells expressed
CD40 at resting state and the expression of this antigen
was found to increase following stimulation with LPS
(Additional file 1: Figure S2). In general, the extracts did
not significantly alter CD40 expression in activated BV2
microglia cells. The extracts-induced alteration of CD40
expression, however, was observed amongst BV2 cells at
resting state. At 24 h, extracts HAB16R12, HAB16R14
and HAB16R18 significantly (P < 0.05) increased CD40
expression on unstimulated BV2 cells [Fig. 3(b)]. On the
other hand, 48 h incubation with extract HAB16R13
significantly (P < 0.05) suppressed CD40 expression on
unstimulated BV2 cells by 53.4 % (Fig. 3(c)).
Endophytic extracts suppressed IL-6 and TNF-α in
stimulated BV2 microglia cells
In the CNS, proinflammatory cytokines are produced
primarily from activated microglia and are involved in
the pathogenesis of brain inflammation [1]. In order to
investigate the effects of endophytic extracts (0.1 mg/ml)
on production of pro- and anti-inflammatory molecules,
the amounts of IL-6, IL-10, IL-12p70, TNF-α, MCP-1
Fig. 2 Effects of pre-treatment with extracts HAB16R12 (a), HAB16R13 (b), HAB16R14 (c), HAB16R18 (d) and HAB8R24 (e) on BV2 microglia cell
viability. Each value is mean percentage ± SEM of three independent experiments. #P < 0.05, when compared to control group (BV2 resting),
*P < 0.05, when compared to the LPS-treated group
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and IFN-γ in treated BV2 microglia cells were measured
using a FACSCalibur flowcytometer. IL-6 level in un-
stimulated BV2 microglia cells were below the limit
of detection (5 pg/mL). Cells stimulated with LPS, on
the contrary, produced high IL-6 (Table 1). All five ex-
tracts significantly (P < 0.05) suppressed IL-6 production
(47.5–87.3 %) with extract HAB16R12 showing the
greatest effect (84.2 % and 87.3 % at 24 h and 48 h,
respectively) (Table 1; P < 0.05). Similar trend was also
observed with TNF-α production. All five extracts re-
duced TNF-α (50.7–89.7 %) with extract HAB16R14
yielding the greatest suppression (89.7 % and 81.3 %) at
24 h and 48 h (Table 2; P < 0.05). The extracts, however,
elicited no significant effect against IL-10, IL-12p70 and
IFN-γ in BV2 microglia cells (data not shown). BV2
microglia cells exhibited very low expression of these
Fig. 3 Effect of endophytic extracts on CD40 expression of BV2 microglia at 18 h (a), 24 h (b) and 48 h (c). Results expressed in percentage of
BV2 CD40 are mean ± SEM of three independent experiments. *P < 0.05 when compared to control group (BV2)
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cytokines (<45 pg/mL) be it in the presence (stimulated
by) or absence (unstimulated by) of LPS. For MCP-1,
the levels produced by the microglia cells were beyond
the detectable range of this assay.
Discussion
Efforts in the past decade have been made to develop
anti-inflammatory agents that are capable of inhibiting
microglia activation and preventing neuronal cell death.
The long-term use of the anti-inflammatory drugs is limited
by of their side effects. As such, there have been many
attempts uncover alternative anti-inflammatory agents
from natural sources. There were already reports of anti-
inflammatory activity by metabolites of several fungal and
actinomycetous endophytes using in vitro and in vivo
model. Phomol, 4-arylcoumarins and ergoflavin produced
by endophytes showed anti-inflammatory activity using
reporter gene assays and in ear oedema model in mice
[17], murine macrophage RAW 264.7 cells [18] and human
monocytic cell line [19], respectively. None of the reports,
however, documented the anti-inflammatory activity of en-
dophytes aganinst activated microglia cells. Thus, this is the
first attempt to investigate anti-inflammatory properties of
endophytes using an in vitro model of microglia cells.
Cytospora sp. has been previously reported to produce
antibiotics: cytosporacin [20], grahamimycin A [21], cytos-
kyrin A [22], cytosporone E [23] and cytosporic acid [24].
Apart from antibacterial effect, cytosporic acid exhibited
antiviral effect. It inhibited a critical enzyme involved in
the replication of HIV with an IC50 of 20 μM [24]. The
pure compound cytoskyrin A displayed poor cytotoxicity
against some tumour cell lines (IC50 > 5 μg/ml) in vitro
[23]. Grahamimycin A, also an anti-fungal agent, did not
induce any toxic symptoms in adult mice [21]. To date,
reports on anti-inflammatory effect of these compounds
are very limited. The association of these compounds with
the anti-inflammatory effect of the tested Malaysian endo-
phytic fungal extracts (HAB16R12, HAB16R13, HAB16R14,
HAB16R18 and HAB8R24) remains unclear.
Inflammation is closely related to pathogenesis of neurode-
generative diseases like Alzheimer’s disease [25], Parkinson’s
disease [26] and multiple sclerosis, as well as cerebral is-
chaemia and post traumatic brain injuries [27]. Microglia
cells are mainly responsible for inducing inflammation
in the CNS. Uncontrolled activation of microglia which
could result in quantitative release of various inflammatory
mediators such as oxygen free radicals and nitric oxide
(NO) has been shown to be directly toxic to neurons [28].
Intervention against the activation process of microglia
may therefore become a promising therapy for the treat-
ment of many neurodegenerative conditions.
In this study, the anti-inflammatory effect of endo-
phytic extracts was investigated against LPS stimulated
microglia. These extracts were previously found to exhibit
excellent BACE1 inhibitory activity [11] and here their pro-
tective effects against inflammation induced NO and pro-
inflammatory cytokines were demonstrated. It is known
that activated microglia release NO and this process has
been implicated as an important mediator in the processes
of CNS inflammation [27]. The present study showed that
pre-treatment with all five endophytic extracts (0.1 and 1.0
mg/ml dose) significantly (p < 0.05) lowered NO produc-
tion in LPS-activated BV2 cells with no significant effect
on basal NO release by the cells. Extracts at 1.0 mg/mL,
Table 1 Effect of endophytic extracts (0.1 mg/mL) on the
secretion of IL-6 in BV2 microglia cells1
IL-6 production (pg/ml)
Stimulated with LPS
24 h ± SEM 48 h ± SEM
BV2 3335.90 ± 935.3 3295.36 ± 1171.4
HAB16R12 528.02 ± 308.0* 417.13 ± 229.5*
HAB16R13 1750.67 ± 325.1* 1513.50 ± 385.7*
HAB16R14 1151.70 ± 92.3* 1058.67 ± 46.1*
HAB16R18 1463.44 ± 189.5* 1327.50 ± 160.8*
HAB8R24 745.14 ± 344.2* 652.32 ± 298.5*
1Data are expressed as means ± SEM of three independent experiments. *P < 0.05,
significantly different when compared to LPS-treated control (BV2)
Table 2 Effect of endophytic extracts (0.1 mg/mL) on the secretion of TNF-α in BV2 microglia cells1
TNF-α production (pg/mL)
Unstimulated Stimulated with LPS
24 h ± SEM 48 h ± SEM 24 h ± SEM 48 h ± SEM
BV2 33.84 ± 3.3 45.78 ± 13.5 4102.62 ± 999.7 2627.97 ± 432.3
HAB16R12 42.44 ± 21.7 61.80 ± 29.8 1150.71 ± 701.4* 1050.06 ± 577.7*
HAB16R13 43.33 ± 1.9 79.82 ± 2.7 960.88 ± 222.7* 982.20 ± 134.8*
HAB16R14 23.83 ± 4.6 58.51 ± 1.2 424.63 ± 98.0* 490.96 ± 86.7*
HAB16R18 32.22 ± 6.1 73.15 ± 0.9 1072.08 ± 332.7* 1052.11 ± 193.7*
HAB8R24 77.28 ± 6.4 103.56 ± 9.1 1511.54 ± 174.5* 1295.21 ± 265.6*
1Data are expressed as means ± SEM of three independent experiments. *P < 0.05, significantly different when compared to LPS-treated control (BV2)
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however, was toxic to BV2 cells and the reduced NO levels
for cells pre-treated at this dosage was likely attributed to
the pronounced cell loss. Interestingly, pre-treatment with
extracts at 0.1 mg/ml was generally more effective than
L-NAME, an iNOS inhibitor, in lowering NO production
in activated microglia. The mechanism underlying the NO
lowering effects by endophytic extracts remains poorly
understood. There is, however, a large number of studies
have considered that the antagonistic effects of natural
compounds on NO production are due to suppression of
NFĸB [29].
Microglial cells express the costimulatory molecule
CD40 upon activation [30–32]. CD40 is considered as a
member of the tumour necrosis factor receptor (TNF-R)
superfamily and is expressed as a 45–50 kD cell surface
molecule. Interaction between CD40 on microglia cells and
its ligand on T lymphocytes triggers a series of intracellular
signaling events that further propagate inflammation [33].
The relationship between the pharmacological effects of
the present tested endophytic extracts with CD40 expres-
sion on BV2, be it at resting or activated state, remains
unclear and requires further investigations. This is because
the extracts, which were found to affect baseline expres-
sion of CD40, exhibited no effect against elevated ex-
pression of the said antigen on activated cells. The overall
effect of the tested endophytic extracts against CD40 ex-
pression on unstimulated BV2, in particular, was bizarre
and failed to exhibit an apparent trend. Three endophytic
extracts (HAB16R12, HAB16R14 and HAB16R18) in-
creased the expression of the said antigen on cells at rest-
ing state. The changes, however, appeared to be temporary
(24 h) as the elevated expression of CD40 on treated cells
was found to be restored to baseline level following pro-
longed incubation (48 h). Yet another extract, HAB16R13,
significantly attenuated CD40 expression on unstimulated
BV2 cells after 48 h. Nevertheless, given none of the
extracts significantly affect CD40 expression on acti-
vated microglia, the present study postulates that the
anti-inflammatory effect as induced by the endophytic ex-
tracts could be independent of CD40 expression. Acti-
vated microglial cells are also known to highly express
other biochemical markers like CD 11c, CD68 and LN-3
[34]. It may be worth exploring the correlation the ex-
tracts with these markers in the future.
Besides NO, excessive production of inflammatory me-
diators such as proinflammatory cytokines including
interleukin-1 beta (IL-1β) and tumor necrosis factor
(TNF) from activated microglia contributes to uncon-
trolled inflammation in neurodegenerative diseases [35].
Here, the effects of five endophytic extracts against vari-
ous inflammatory cytokines (IL-6, IL-10, IL-12p70, TNF-
α, and IFN-γ) and chemokine (MCP-1) were studied. At
0.1 mg/mL, all extracts inhibited expression of proin-
flammatory cytokines, namely IL-6 and TNF-α in LPS-
activated microglia. The extracts, however, exhibited no
effect against the rest of the proinflammatory cytokines
(IL-10, IL-12p70 and IFN-γ). The results from the present
study also showed that BV2 cells itself did not up-regulate
these cytokines even after LPS stimulation. TNF-α and
IL-6 are amongst the main proinflammatory cytokines
that are produced by activated microglia during CNS in-
flammation [36]. Indeed, these cytokines are abundantly
induced in brain microglia by stimulants such as LPS [37],
IFN-γ, amyloid-β [38]. TNF-α and IL-6 appear to play a
dual role in brain injury and neurodegeneration that in-
clude both neurotrophic and neurotoxic effects [39].
A potential anti-inflammatory role of these endophytic
fungal extracts on microglia is indicated. Although this
study was performed on LPS-stimulated BV2 microglia
cells, this paradigm partially reflects the pathological con-
dition where activated microglia influences neuron viabil-
ity [35]. Further studies are required to fully assess the
limiting effects of these extracts on microglia functionality
and the ability of such metabolites to cross the blood brain
barrier and remain effective.
Conclusions
In conclusion, the results demonstrated that these endo-
phytic extracts exerted inhibitory effect against NO and
proinflammatory cytokines (IL-6 and TNF-α) produced
by activated BV2 microglia. It is likely that they would
have a neuroprotective effect against inflammation result-
ing from the presence of inflammatory mediators such as
NO, IL-6 and TNF-α in activated BV2 microglia. To our
knowledge, this is the first report of the effect of a fungal
endophytic extract in controlling inflammation in BV2
microglia cells.
Additional file
Additional file 1: Figure S1. As a reference, cells were pre-treated
only with endophytic extracts HAB16R12 (a), HAB16R13 (b), HAB16R14
(c), HAB16R18 (d) and HAB8R24 (e) for 18 h, 24 h and 48 h, and the
culture supernatant subjected to nitrite quantification. Data are expressed as
means ± SEM of three independent experiments. Figure S2: CD40
expression of unstimulated and LPS-stimulated BV2 microglia as
determined by immunophenotyping.
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